Inhibitor-2 induced M-phase arrest in Xenopus cycling egg extracts is dependent on MAPK activation

Arian Khandani1, Mahmood Mohtashami, Anne Camirand

  • 1Department of Cell Biology, University of Alberta, Edmonton, Alberta, Canada, T6G 2H7 arian.khandani@sickkids.ca.

Insights

Inhibitor-2 protein triggers M-phase arrest in Xenopus egg extracts, dependent on mitogen-activated protein kinase (MAPK) activity. This study reveals a new link between MAPK and protein phosphatase 1 (PP1) pathways in cell cycle regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Protein phosphatase 1 (PP1) is crucial for dephosphorylating phosphoproteins during M phase.
  • Inhibitor-2 (Inh-2), a PP1 inhibitor, is known to play a role in regulating PP1 activity.

Purpose of the Study:

  • To investigate the role of Inh-2 in cell cycle regulation.
  • To determine if Inh-2-induced M-phase arrest is dependent on the mitogen-activated protein kinase (MAPK) pathway.
  • To elucidate the mechanism linking PP1 and MAPK pathways during M phase.

Main Methods:

  • Xenopus cycling egg extracts were used to study M-phase arrest.
  • The effect of Inh-2 on M-phase progression was analyzed.
  • MAPK activity was inhibited using PD98059 to assess its role in Inh-2-induced arrest.
  • Phosphorylation of Inh-2 by p90Rsk was investigated.

Main Results:

  • Inhibitor-2 (Inh-2) induces M-phase arrest in Xenopus egg extracts.
  • This M-phase arrest is dependent on mitogen-activated protein kinase (MAPK) activity.
  • Inhibition of MAPK by PD98059 prevents Inh-2-induced M-phase arrest.
  • Phosphorylation of Inh-2 by p90Rsk is not required for its function in inducing M-phase arrest.

Conclusions:

  • Inh-2 induces M-phase arrest through a mechanism that requires MAPK activity.
  • A novel link between the MAPK and PP1 pathways in regulating M phase is suggested.
  • The phosphorylation status of Inh-2 by MAPK is not essential for its role in cell cycle arrest.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Meiosis II02:02

Meiosis II

Meiosis II entails cell division and segregation of the sister chromatids, resulting in the production of four unique haploid gametes. The steps for meiosis II are similar to mitosis, except that meiosis II occurs in haploid cells, whereas mitosis occurs in diploid cells.
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
Meiosis II01:57

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...